Full metadata record

DC Field Value Language
dc.contributor.authorBhattarai, Deepak-
dc.contributor.authorLee, Sun H.-
dc.contributor.authorSeo, Seon H.-
dc.contributor.authorNam, Ghilsoo-
dc.contributor.authorKang, Soon B.-
dc.contributor.authorPae, Ae N.-
dc.contributor.authorKim, Eunice E.-
dc.contributor.authorOh, Taegwon-
dc.contributor.authorCho, Sang-Nae-
dc.contributor.authorKeum, Gyochang-
dc.date.accessioned2024-01-20T14:03:20Z-
dc.date.available2024-01-20T14:03:20Z-
dc.date.created2021-09-05-
dc.date.issued2012-09-
dc.identifier.issn1747-0277-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/128932-
dc.description.abstractWe synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings. Acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. The resulting series of compounds was then screened in vitro against panel of susceptible and resistant Gram-positive, Gram-negative bacteria, and Mycobacterium tuberculosis (Mtb). Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against the tested bacteria. Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M.similar to tuberculosis. Selected compound 10b showed good human microsomal stability and CYP-profile, and showed low activity against hERG channel.-
dc.languageEnglish-
dc.publisherWILEY-
dc.subjectRESISTANT STAPHYLOCOCCUS-AUREUS-
dc.subjectLINEZOLID-RESISTANT-
dc.subjectMYCOBACTERIUM-TUBERCULOSIS-
dc.subjectMULTIDRUG-RESISTANT-
dc.subjectMURINE MODEL-
dc.subjectAGENTS-
dc.subjectINFECTIONS-
dc.subjectEPIDERMIDIS-
dc.subjectSYSTEM-
dc.subjectGENE-
dc.titleSynthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones-
dc.typeArticle-
dc.identifier.doi10.1111/j.1747-0285.2012.01404.x-
dc.description.journalClass1-
dc.identifier.bibliographicCitationCHEMICAL BIOLOGY & DRUG DESIGN, v.80, no.3, pp.388 - 397-
dc.citation.titleCHEMICAL BIOLOGY & DRUG DESIGN-
dc.citation.volume80-
dc.citation.number3-
dc.citation.startPage388-
dc.citation.endPage397-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000306664800006-
dc.identifier.scopusid2-s2.0-84864135918-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusRESISTANT STAPHYLOCOCCUS-AUREUS-
dc.subject.keywordPlusLINEZOLID-RESISTANT-
dc.subject.keywordPlusMYCOBACTERIUM-TUBERCULOSIS-
dc.subject.keywordPlusMULTIDRUG-RESISTANT-
dc.subject.keywordPlusMURINE MODEL-
dc.subject.keywordPlusAGENTS-
dc.subject.keywordPlusINFECTIONS-
dc.subject.keywordPlusEPIDERMIDIS-
dc.subject.keywordPlusSYSTEM-
dc.subject.keywordPlusGENE-
dc.subject.keywordAuthorantibacterial agents-
dc.subject.keywordAuthordrug design-
dc.subject.keywordAuthordrug discovery-
dc.subject.keywordAuthorMycobacterium tuberculosis-
dc.subject.keywordAuthoroxazolidinone-
Appears in Collections:
KIST Article > 2012
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE